Assessment of morbid obesity-associated comorbidities progression after surgical treatment with the duodenal crossing technique;Valoración de la evolución de las comorbilidades de la obesidad mórbida tras tratamiento quirúrgico mediante la técnica del cruce duodenal

Nutricion Hospitalaria

Volumn 22, Issue 5, 2007, Pages 596-601

  Vázquez Prado, Antonio ^a   Montalva Oron E Ma ^a   De Tursi Rispoli L C ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Arterial hypertension; Comorbidity; Diabetes; Duodenal crossing; Dyslipidemia; Morbid obesity; OSAS; Osteoarticular impairment; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DUODENUM; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; OSTEOARTHROPATHY; POSTOPERATIVE PERIOD; SCORING SYSTEM; SURGICAL TECHNIQUE; WEIGHT REDUCTION;

ADULT; AGED; BARIATRIC SURGERY; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES MELLITUS; DISEASE PROGRESSION; DUODENUM; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; OSTEOARTHRITIS; PROSPECTIVE STUDIES; REMISSION INDUCTION; SLEEP APNEA, OBSTRUCTIVE; SPAIN;

EID: 35548940432     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Woods P, Paquette C, Martin J, Dumesnil JG, Marceau P, Marceau S, Biron S, Hould F, Lescelleur O, Lebel S, Poirier P. Bariatric surgery for severe obesity. J Assoc Acad Minor Phys 2001; 12:129-36.
2. Jones DB, Provost DA, DeMaria EJ, Smith CD, Morgenstern L, Schirmer B. Optimal management of the morbidly obese patient. SAGES appropriateness conference statement. Surg Endosc 2004; 18:1029-37.
3. Bender R, Jockel KH, Trautner C, Spraul M, Berger M. Effect of age on excess mortality in obesity. JAMA 1999; 281:1498-1504.
4. Drenick EJ, Bale GS, Seltzer F, Jonson DG. Excessive mortality and causes of death in morbidly obese men. JAMA 1980; 243:443-5.
5. Peluso L, Vanek VW. Efficacy of gastric bypass in the treatment of obesity-related comorbidities. Nutr Clin Pract 2007; 22:22-8
6. Stocker J. Management of the bariatric surgery patient. Endocrinol Metab Clin N Am 2003; 32:437-57.
7. Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg 1998; 8:267-82.
8. Oria HE, Moorehead MK. Bariatric analysis and reporting outcome system (BAROS). Obes Surg 1998; 8:487-99.
9. Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003; 237:751-6.
10. Fontaine KR, Redden DT, Wang C, Fontaine KR, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003; 289:187-93.
11. Wolf AM, Colditz GA. Current estimates of the economic costs of obesity in the United Status. Obes Res 1998; 6:97-106.
12. Gabinete de Estudios Sociológicos Bernard Krief. Estudio prospectivo Delphi. Costes sociales y económicos de la obesidad y sus patologías asociadas (hipertensión, hiperlipidemias y diabetes) Madrid: NILO Industria Gráfica S. A., 1999; 13-23.
13. Stocker J. Management of the bariatric surgery patient. Endocrinol Metab Clin N Am 2003; 32:437-57.
14. Schauer PR, Ikramuddin S. Laparoscopic surgery for morbid obesity. Surg Clin N Am 2001; 81:1145-79.
15. Simard B, Turcotte H, Marceau P, Biron S, Hould FS, Lebel S, Marceau S, Boulet LP. Asthma and sleep apnea in patients with morbid obesity: outcome after bariatric surgery. Obes Surg 2004; 14:1381-88.
16. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292:1724-37.
17. Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003; 237:751-6.
18. Jung RT. Obesity as a disease. British Medical Bulletin 1997; 53:307-21.
19. Clinical Guidelines on the identification, evaluation and treatment of overweight and obesity in adults. Nacional Institutes of Healt, 1998. Publication no. 98-4083.
20. Feng J, Gagner M. Laparoscopic biliopancreatic diversión with duodenal switch. Semin Laparosc Surg 2002; 9:125-9.
21. Dolan K, Hatzifotis M, Newbury L, Lowe N, Fielding G. A Clinical and nutritional comparison of biliopancreatic diversion with and without duodenal switch. Annals of Surgery 2004; 240:51-6.
22. Baltasar A, Bou R, Miró J, Bengochea M, Serra C, Pérez N. Laparoscopic biliopancreatic diversion with duodenal switch: technique and initial experience. Obes Surg 2002; 12:245-8.
23. Livingston EH, Huerta S, Arthur D, et al. Male gender is a predictor of morbidity and age a predictor of mortality for patients undergoing gastric bypass surgery. Ann Surg 2002; 236:576-82.
24. Van Hee HGG. Biliopancreatic diversion in the surgical treatment of morbid obesity. World J Surg 2004; 28:435-44.
25. 2) compared with gastric bypass. Ann Surg 2006; 244:611-19.
26. Strain GW, Gagner M, Inabnet WB, Dakin G, Pomp A. Comparison of effects of gastric bypass and biliopancreatic diversion with duodenal switch on weight loss and body composition 1-2 years after surgery. Surg Obes Relat Dis 2007; 3:31-6.
27. Anthone GJ, Señor RV, DeMeester TR, Crookes PF. La operación duodenal del interruptor para el tratamiento de la obesidad mórbida. Ana Surg 2003; 238 :618-27.
28. Balsiger BM, Murr MM, Poggio JL, Sarr MG. Bariatric surgery. Surgery for weight control in patients with morbid obesity. Med Clin N Am 2000; 84:477-89.